<i>C. elegans</i> (VIDEO)
Caption
Texas Engineers have developed the first large-scale in vivo drug discovery platform using <i>C. elegans</i> -- a transparent roundworm that is used in the study of neurodegenerative diseases, including Parkinson's, Huntington's and Alzheimer's.
Credit
Cockrell School of Engineering
Usage Restrictions
None
License
Licensed content